Henry Wang, Shravankrishna Ananthapadmanabhan, Jake Rahkala, Jeremy Saad, Ramesh Shanmugasundaram, Zoe Williams, Varun Bhoopathy, Brayden March, Mohan Arianayagam, Nicholas Mehan, Michael Myint, Bertram Canagasingham, Isaac A Thangasamy
{"title":"前列腺癌局灶性治疗的综述。","authors":"Henry Wang, Shravankrishna Ananthapadmanabhan, Jake Rahkala, Jeremy Saad, Ramesh Shanmugasundaram, Zoe Williams, Varun Bhoopathy, Brayden March, Mohan Arianayagam, Nicholas Mehan, Michael Myint, Bertram Canagasingham, Isaac A Thangasamy","doi":"10.31128/AJGP-12-24-7489","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Focal therapy is an emerging treatment modality for prostate cancer that aims to spare patients treatment-related side effects including erectile dysfunction and urinary incontinence associated with surgery and radiotherapy, which are the current standards of care.</p><p><strong>Objective: </strong>In this narrative review, the authors aim to provide a focused summary of prostate cancer focal therapies for general practice including an overview of key underlying oncological principles, existing treatment modalities, their functional and oncological outcomes, and follow-up after treatment.</p><p><strong>Discussion: </strong>Focal therapy is being increasingly established in the management of localised prostate cancer and is a promising alternative to surgery and radiotherapy in carefully selected patients. With a growing body of evidence in support of focal therapy, its potential in the future of prostate cancer management is clear.</p>","PeriodicalId":54241,"journal":{"name":"Australian Journal of General Practice","volume":"54 9","pages":"654-658"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A review of prostate cancer focal therapies in general practice.\",\"authors\":\"Henry Wang, Shravankrishna Ananthapadmanabhan, Jake Rahkala, Jeremy Saad, Ramesh Shanmugasundaram, Zoe Williams, Varun Bhoopathy, Brayden March, Mohan Arianayagam, Nicholas Mehan, Michael Myint, Bertram Canagasingham, Isaac A Thangasamy\",\"doi\":\"10.31128/AJGP-12-24-7489\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Focal therapy is an emerging treatment modality for prostate cancer that aims to spare patients treatment-related side effects including erectile dysfunction and urinary incontinence associated with surgery and radiotherapy, which are the current standards of care.</p><p><strong>Objective: </strong>In this narrative review, the authors aim to provide a focused summary of prostate cancer focal therapies for general practice including an overview of key underlying oncological principles, existing treatment modalities, their functional and oncological outcomes, and follow-up after treatment.</p><p><strong>Discussion: </strong>Focal therapy is being increasingly established in the management of localised prostate cancer and is a promising alternative to surgery and radiotherapy in carefully selected patients. With a growing body of evidence in support of focal therapy, its potential in the future of prostate cancer management is clear.</p>\",\"PeriodicalId\":54241,\"journal\":{\"name\":\"Australian Journal of General Practice\",\"volume\":\"54 9\",\"pages\":\"654-658\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Australian Journal of General Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.31128/AJGP-12-24-7489\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian Journal of General Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31128/AJGP-12-24-7489","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
A review of prostate cancer focal therapies in general practice.
Background: Focal therapy is an emerging treatment modality for prostate cancer that aims to spare patients treatment-related side effects including erectile dysfunction and urinary incontinence associated with surgery and radiotherapy, which are the current standards of care.
Objective: In this narrative review, the authors aim to provide a focused summary of prostate cancer focal therapies for general practice including an overview of key underlying oncological principles, existing treatment modalities, their functional and oncological outcomes, and follow-up after treatment.
Discussion: Focal therapy is being increasingly established in the management of localised prostate cancer and is a promising alternative to surgery and radiotherapy in carefully selected patients. With a growing body of evidence in support of focal therapy, its potential in the future of prostate cancer management is clear.
期刊介绍：
The Australian Journal of General Practice (AJGP) aims to provide relevant, evidence-based, clearly articulated information to Australian general practitioners (GPs) to assist them in providing the highest quality patient care, applicable to the varied geographic and social contexts in which GPs work and to all GP roles as clinician, researcher, educator, practice team member and opinion leader. All articles are subject to peer review before they are accepted for publication.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
